ASN95 -- Selected abstracts in PERITONEAL DIALYSIS

Sunday Nov. 5 1995

9:30AM ---Poster--- San Diego Conv Ctr Halls A and B

Dialysis Adequacy: Estimates and Results

Program Number 231 board# S231 at 10:45 A.M.
* Predictive Value of Adequacy and Nutritional indices on Mortality and Morbidity on CAPD and HD. A longitudinal Study. R. Maiorca, G. Brunori, R. Zubani, G.C. Cancarini, L. Manili, C. Camerini, E. Movilli, A. Pola, G. D'avolio and U. Gelatti. - Brescia, Italy.

Program Number 237 board# S237 at 10:45 A.M.
* Dialysis Adequacy and Nutrition in CAPD: A prospective Study. J.C. Harty, H. Boulton, M.C. Venning and R. Gokal. - Manchester, United Kingdom.

Program Number 240 board# S240 at 10:45 A.M.
* Correlation Between Peritoneal Transport Type and Peritoneal Protein Losses. A. Cueto-manzano, G. Gamba, L. Guerrero and R. Correa-rotter. - Mexico City, Mexico.

Program Number 244 board# S244 at 10:45 A.M.
* The Creatinine Excretion Ratio Is An Unreliable indicator of Non-compliance in PD Patients. P.G. Blake, E. Spanner, S. Mcmurray, R.M. Lindsay and E. Ferguson. - London, Canada.

Program Number 249 board# S249 at 10:45 A.M.
* Effect of Amino Acid Based Dialysate on Peritoneal Blood Flow and Permeability During CAPD. C.E. Douma, D.R. De Waart, D.G. Struijk and R.T. Krediet. - Amsterdam, The Netherlands.

Program Number 254 board# S254 at 10:45 A.M.
* Total Body Water in Chronic Peritoneal Dialysis Patients. W. Arkouche, D. Fouque, C. Pacchiaudi, S. Normand, M. Laville, E. Delawari, R. Sibai-galland, J. Traeger, J.P. Riou and M. Laville. - Lyon, France.

Program Number 255 board# S255 at 10:45 A.M.
* investigation of APEX (accelerated Peritoneal Equilibration Examination) As The Estimation of Peritoneal Function. S. Kumon, D. inaguma and Y. Watanabe. - Seto, Japan.

Program Number 257 board# S257 at 10:45 A.M.
* Plasma Iohexol Clearance Can Reliably Measure Adequacy of Cycler Peritoneal Dialysis. C.L. Shuler, M.A. Marx and T.A. Golper. - Portland, Or and Little Rock, Ar.

4:00PM ---minisymposia--- San Diego Conv Ctr Rm 5ab
Adequacy of Dialysis

Program Number 623 at 4:15
* Comparison of 2 year Survival on Hemodialysis and Peritoneal Dialysis With Dose of Dialysis Matched Using The Peak Concentration Hypothesis. P. Keshaviah, J. Ma, K. Thorpe, D. Churchill and A. Collins. - Minneapolis, Mn and Hamilton, Canada.

Program Number 624 at 4:30
* Association Between Adequacy and Nutrition in CAPD - genuine Or Artifact? J.E. Tattersall, M.A. Marx and T.A. Golper. - Stevenage, United Kingdom and Little Rock, Ar.

Mon. Nov. 6 1995

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Hemodynamic/cardiovascular Relationships of Dialysis/end-stage Renal Disease

Program Number 807 board# M76 at 10:00 A.M.
* Cardiac Disease in Endstage Renal Disease: A comparison of Hemodialysis and Peritoneal Dialysis. J.D. Harnett, G. Kent, R. Foley, D. Murray, P. Barre and P. Parfrey. - St. John's and Montreal, Canada.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Health Service Research

Program Number 842 board# M111 at 10:00 A.M.
* Are Children Treated at Adult vs Pediatric Dialysis Facilities More Likely To Receive Hemo vs Peritoneal Dialysis? S. Furth, W. Hwang, A. Neu, B.A. Fivush and N.R. Powe. - Baltimore, Md.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Complications and Outcomes in End-stage Renal Disease I

Program Number 873 board# M142 at 10:00 A.M.
* Residual Renal Function in Hemodialysis and Continuous Ambulatory Peritoneal Dialysis Patients. B. Bhatla, K.D. Nolph, H. Moore, B. Prowant, Z. Twardowski, R. Khanna and G. PETroski. - Columbia, Mo.

Program Number 874 board# M143 at 10:00 A.M.
* Long-term Combination Home Automated Peritoneal Dialysis and in-center Hemodiafiltration for Progressive Neuropathy in End Stage Renal Disease. M. Schreiber, E. Paganini, D. Benarz and R. Shields. - Cleveland, Oh.

Program Number 885 board# M154 at 10:00 A.M.
* Increased Risk of Adverse Outcome in Immunosuppressed Patients Undergoing CAPD. K.J. Warr, P.A. andrews, J.A. Hicks, C.S. Ogg and J.S. Cameron. - London, United Kingdom.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B Lipid Metabolism in Dialysis Patients

Program Number 977 board# M246 at 10:00 A.M.
* Effect of Serum Subfractions From CAPD Patients on Hepatic Synthesis of Apo A-i. G.M. Shah, Z-l. Lin, R. Pai, D.D. Roh, F-y. Jin, M.L. Kashyap, V.S. Kamanna and M.A. Kirschenbaum. - Long Beach and Irvine, Ca.

Program Number 978 board# M247 at 10:00 A.M.
* CAPD Patients With Cardiovascular Disease Have increased Lp(a) Levels Grich May Be Associated With Decreased Survival. R. Sreedhara, M.M. Avram, P. Fein, M. Javed and N. Mittman. - Brooklyn, Ny.

Program Number 984 board# M253 at 10:00 A.M.

* Formula To Calculate Nitrogen Losses in Patients Treated With Chronic Peritoneal Dialysis. A. Edefonti, M. Picca, G. Consalvo, L. Ghio, A. Carcano, A. Dalcol and R. Galato. - Milan, Italy.

Program Number 985 board# M254 at 10:00 A.M.
* Lean Body Mass Estimation By Different Techniques in Healthy Controls and Peritoneal Dialysis Patients. H.F.H. Brulez, J. Roos, A.J.M. Donker and P.M. Ter Wee. - Amsterdam, The Netherlands.

Program Number 986 board# M255 at 10:00 A.M.
* Comparison of Methods Used To Assess Fat Free Mass in CAPD Patients. K.C. Wong, D.J. Borovnicar, P.G. Kerr, D.B. Stroud, B.J.G. Strauss and R.C. atkins. - Clayton, Australia.

Program Number 987 board# M256 at 10:00 A.M.
* A comparison of Several Bioelectrical Impedance Equations To Assess Lean Body Mass in Peritoneal Dialysis Patients. C.W.H. De Fijter, L.P. Oe, M. De Fijter, A.J.M. Donker and P.M.J.M. De Vries. - Amsterdam, The Netherlands.

Program Number 993 board# M262 at 10:00 A.M.
* Effect of insulin-like Growth Factor 1 on Nitrogen Balance in Malnourished CAPD Patients. E. Shahmir, S. Peng, D. Fouque and J.D. Kopple. - Torrance, Ca.

Program Number 1000 board# M269 at 10:00 A.M.
* Use of A 1.1;Pc Amino-acid Dialysis Solution To Treat Malnutrition in Peritoneal Dialysis Patients. M. Jones, T. Hagen, E. Vonesh and J. Moran. - Mcgaw Park, Il.

Program Number 1001 board# M270 at 10:00 A.M.
* Hypokalemia in CAPD Patients: Role of Malnutrition. A. Gonzalez and R.M. Raja. - Philadelphia, Pa.

Program Number 1002 board# M271 at 10:00 A.M.
* The Effect of Dialysis Dose on The Preservation of Lean Body Mass in CAPD Patients. S.W. Lee, S.W. Kang, K.H. Choi, H.Y. Lee and D.S. Han. - Seoul, Korea.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Modeling in Dialysis: Techniques and Applications Ii

Program Number 1011 board# M280 at 10:00 A.M.
* Urea and Creatinine Weekly Clearances Measured By Direct Quantification: Comparison in Apd, CAPD and Conventional HD. J. Chanliau, P-y. Durand, J. Mallie and M. Kessler. - Nancy, France.

Program Number 1012 board# M281 at 10:00 A.M.
* Plasminogen Activator inhibitor-1 and Peritoneal Transport in Diabetic and Non-diabetic Dialysis Patients. N.K. Wadhwa, J-j. Lin, L. Parton and G. Bereket. - Stony Brook, Ny.

Program Number 1019 board# M288 at 10:00 A.M.
* Difference in Reduction of Tubular Creatinine Secretion By Cimetidine Between CAPD and HD Pts. R.W. Van Olden, R.T. Krediet, D.G. Struijk and L. Arisz. - Amsterdam, The Netherlands.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Basic Immunology: Fibroinflammatory Responses

Program Number 1116 board# M385 at 10:00 A.M.
* Phenotypic Studies of Human Peritoneal Macrophages of Patients With Bacterial Peritonitis During Ex Vivo Differentiation. N. Almanasreh, M. Sach, K. Bauermeister, H.P. Knopf, P. Schollmeyer and G.J. Dobos. - Freiburg, Germany.

Tue. Nov. 7, 1995

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Electrolyte and Acid-base Disorders Program Number 1496 board# T46 at 10:00 A.M.
*Intracellular Ph and Na/h Antiporter Activity in Uremic Patients on Peritoneal Dialysis Treatment. G. Rombola, M.E. De Ferrari, R. Galato, A. Da Col and G. Civati. - Milan, Italy.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Complications and Outcomes in End-stage Renal Disease Iii

Program Number 1599 board# T149 at 10:00 A.M.
*Characteristics of Long-term Peritoneal Dialysis Survivors. E.M. Abdel-rahman, M.J. Wakeen and S.W. Zimmerman. - Madison, Wi.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Access Methods of Peritoneal Dialysis

Program Number 1613 board# T163 at 10:00 A.M.
* Low I.P. Pressure Causes Fluid Loss From The Peritoneal Cavity To The Body. M.F. Flessner. - Rochester, Ny.

Program Number 1616 board# T166 at 10:00 A.M.
* Simple and inexpensive Determination of Weekly Kt/v for Peritoneal Dialysis Patients. G.J. Mishkin, F. Azali and J.P. Bosch. - Washington, Dc.

Program Number 1617 board# T167 at 10:00 A.M.
* Mass Transfer Across Specific Peritoneal Tissue Surfaces in The Rat. M.F. Flessner. - Rochester, Ny.

Program Number 1618 board# T168 at 10:00 A.M.
* Endogenous Erythropoietin Levels Are Elevated in Patients on Continuous Ambulatory Peritoneal Dialysis. B.G. Delano, O. Ifudu, M. Joseph and E.A. Friedman. - Brooklyn, Ny.

Program Number 1619 board# T169 at 10:00 A.M.
* Participation of Water Channels in Peritoneal Water Transport. H. Hayakawa, H. Hasegawa, H. Takahashi, M. Suzuki, Y. Kawaguchi and O. Sakai. - Tokyo and Tochigi, Japan.

Program Number 1620 board# T170 at 10:00 A.M.
* Access-related infection in HIV Sero Positive Dialysis Patients: Comparison of Hemodialysis To Peritoneal Dialysis. J.A. Vassalotti, M. Choi, A. Grelton, W. Briggs, L. Gimenez and P.J. Scheel. - Baltimore, Md.

Program Number 1621 board# T171 at 10:00 A.M.
* Continuous Ambulatory Peritoneal Dialysis Using A self-made, Ultrafiltration-sterilized, Bicarbonate-based Solution. F.K.M. Wong, Y.L. Cheng, A.W. Yu, A.P. Mcshane, V.C. Gandhi and T.S. ing. - Hines, Il.

Program Number 1622 board# T172 at 10:00 A.M.
* Bacteria Grow Better If Ph of CAPD Solutions Is Elevated From 5.0 To 6.4 offsetting Improvement in Neutrophil Phagocytosis. J. Bohler, G. Dobos, M. Sach, J. Passlick-Deetjen and P. Schollmeyer. - Freiburg, Germany.

Program Number 1626 board# T176 at 10:00 A.M.
* Exit Site infection & peritonitis in a rabbit Model of Peritoneal Dialysis With Human Strains of Staphylococcus Aureus. M.K. Dasgupta, P. Leedell and M. Larabie. - Edmonton, Canada.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Clinical and Experimental Peritoneal Dialysis

Program Number 1627 board# T177 at 10:00 A.M.
* Peritoneal Membrane Characteristics in Relation To Peritonitis in Children on CAPD/CCPD. S.P. andreoli, S.L. Watkins, B.A. Warady and E.D. Brewer. - Indianapolis, IN; Seattle, WA; Kansas City, Mo and Houston, Tx.

Program Number 1628 board# T178 at 10:00 A.M.
* Superinduction of Il-6 Synthesis in Human Peritoneal Mesothelial Cells: Stabilization of MRNA by Peritoneal Dialysis Effluent and inflammatory Cytokines. J. Witowski, N. Topley, A. Jorres, G.A. Coles and J.D. Williams. - Cardiff, United Kingdom and Berlin, Germany.

Program Number 1630 board# T180 at 10:00 A.M.
* Glycation of Albumin With Icodextrin. D.J. Millar and A.B.S. Dawnay. - London, United Kingdom.

Program Number 1631 board# T181 at 10:00 A.M.
* High Glucose Stimulates Extracellular Matrix Biosynthesis in Human Peritoneal Mesothelial Cells. F.F. Hou, X. Zhang and Y. Zhang. - Guangzhou, P.R. China.

Program Number 1632 board# T182 at 10:00 A.M.
* Human Peritoneal Fibroblast Proliferation in 3d Culture: induction By PdGF, BFGF, IL-1 beta, and Peritoneal Dialysis Effluent. M.J. Lang and J.D. Williams. - Cardiff, United Kingdom.

Program Number 1633 board# T183 at 10:00 A.M.
* Effect of Acutely Raising The Serum Albumin on Peritoneal Transport and Ultrafiltration in CAPD Patients. J. Worrall, I.C. Macdougall, A.E.G. Raine and A. Dawnay. - London, United Kingdom.

Program Number 1634 board# T184 at 10:00 A.M.
* Time Course of Peritoneal Permeability Changes in a rabbit Model of Peritonitis. F-y. Liu, J.K. Leypoldt and A.K. Cheung. - Salt Lake City, Ut.

Program Number 1635 board# T185 at 10:00 A.M.
* Properties of The Peritoneal Dialysate Effluent and Its Effect on Function of Human Peritoneal Mesothelial Cells. A. Breborowicz, L. Martis and D.G. Oreopoulos. - Poznan, Poland; Mcgaw Park, Il and Toronto, Canada.

Program Number 1636 board# T186 at 10:00 A.M.
* The Role of Nadph in Maintaining Neutrophil Function on Exposure To Peritoneal Dialysis Fluid. S.D. Jayasena, J.S. Hothersall, M.M. Epperlein, G.H. Neild and A.A. Noronha-dutra. - London, United Kingdom.

Program Number 1637 board# T187 at 10:00 A.M.
* Outcome on Peritoneal Dialysis After Renal Transplant Failure. J.T. Klassen, M. Lamptey and J.M. Bargman. - Toronto, Canada.

Program Number 1638 board# T188 at 10:00 A.M.
* Successful Continuous Peritoneal Dialysis in Children Under 5 years of Age. K. Ronnholm, J. Laine, T. Holtta, M. Ala-houhala, H. Jalanko and C. Holmberg. - Helsinki, Finland.

Program Number 1639 board# T189 at 10:00 A.M.
* Pharmacokinetics of Ceftazidime in Patients on Continuous Ambulatory Peritoneal Dialysis. S. Stea, T. Bachelor, M. Cooper, P. De Souza, K. Koenig and W.K. Bolton. - Charlottesville, Va.

Program Number 1640 board# T190 at 10:00 A.M.
* Actual and Desired Frequency of Sexual intercourse in Chronic Peritoneal Dialysis Patients. P. Juergensen, D. Baltimore, S. Finkelstein, D. Jueregensen, A. Kliger, T. Steele and F. Finkelstein. - New Haven, Ct and Charleston, Sc.

Program Number 1641 board# T191 at 10:00 A.M.
* Urokinase Enhancement of Rifampin Activity AgaInst Experimental S. Epidermidis Biofilms in Spent PD Fluid. R.F. Gagnon, G.K. Richards and R. Morcos. - Montreal and Regina, Canada.

Program Number 1642 board# T192 at 10:00 A.M.
* in Vitro Simulation of The Effect of Peritoneal Dialysis Fluid on Mesothelial Cells. A. Breborowicz, H. Rodela, L. Martis and D.G. Oreopoulos. - Poznan, Poland; Toronto, Canada and Mcgaw Park, Il.

Program Number 1643 board# T193 at 10:00 A.M.
* Igg-subclasses in Chronic Ambulatory Peritoneal Dialysis and Chronic Renal Failure of Childhood. M.J. Kemper, T. Meyer-jark and D.E. Muller-wiefel. - Hamburg, Germany.

Program Number 1645 board# T195 at 10:00 A.M.
* Antigen Presentation By Human Peritoneal Mesothelial Cells. A. Douvdevani, B.V. Rogachov and C. Chaimovitz. - Beer-sheva, Israel.

Program Number 1646 board# T196 at 10:00 A.M.
* interleukin-1beta Selectively Enhances Hyaluronan Synthesis By The Human Peritoneal Mesothelial Cell. S. Yung and M. Davies. - Cardiff, United Kingdom.

Program Number 1647 board# T197 at 10:00 A.M.
* Stimulation of Glucose Transporter-1 By Il-1beta in Human Peritoneal Mesothelial Cells. M. Kruse, A. Mahiout, K.M. Koch and R. Brunkhorst. - Hannover, Germany.

Program Number 1648 board# T198 at 10:00 A.M.
* Effect of Peritoneal Dialysis Fluids on Cyclooxygenase (cox-1 and Cox-2) Mrna Expression and Prostaglandin Release By Activated Leukocytes. A. Jorres, G.M. Gahl, N. Topley, U. Frei and J.P. Passblick-deetjen. - Cardiff, United Kingdom; Berlin and Fresenius, Germany.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Clinical Transplantation I

Program Number 1816 board# T366 at 10:00 A.M.
* Reduced incidence of Acute Renal Failure in Patients Treated With CAPD As Compared To HD. P. Heering, M.C. Lambert, M. Glover, B. Grabensee and N. Lemaire. - Dusseldorf, Germany and Gent, Belgium.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Matrix/growth Factor interactions

Program Number 1885 board# T435 at 10:00 A.M.
* Tgf-beta1 Stimulates Mmp-9 in Primary Culture of Human Peritoneal Mesothelial Cells and in a derived Sv40 Transfected Cell Line. J.Ph. Rougier, R. Piedagnel, Ph. Moullier and P.M. Ronco. - Paris, France.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Bone Disease

Program Number 1971 board# T521 at 10:00 A.M.
* Pulse and Daily Oral Calcitriol Are Equally Effective in CAPD Patients. S. Moe, M. Kraus, C. Gassensmith, J. North and M. Peacock. - indianapolis, in.

9:00AM ---Poster--- San Diego Conv Ctr Halls A and B
Cytokines/inflammatory Mediators

Program Number 2016 board# T566 at 10:00 A.M.
* Mononuclear Cell Migration Across Human Peritoneal Mesothelial Cell (hpmc) Monolayers: The Roles of Hpmc Derived Mcp-1 and Rantes. F-k. Li, P. Loetscher, J.D. Williams and N. Topley. - Cardiff, United Kingdom and Switzerland.

Program Number 2017 board# T567 at 10:00 A.M.
* Human Peritoneal Mesothelial Cells increase PMn Migration Via The Creation of a local Apical To Basolateral Il-8 Chemotactic Gradient. A. Davenport, N. Topley and J.D. Williams. - Cardiff, United Kingdom.

4:00PM ---Free Communications--- San Diego Conv Ctr Rm 8
Access for and Methods of Dialysis II

Program Number 2045 at 4:30
* Peritoneal Membrane Transport Function in Children: A report of The Pediatric Peritoneal Dialysis Study Consortium. B.A. Warady, S. Alexander, S. Hossli, E. Vonesh, D. Geary, S. Watkins, I. Salusky and E. Kohaut. - Kansas City, Mo.

Program Number 2046 at 4:45
* Reproducibility of The Concentration-time Profile During The Peritoneal Equilibration Test. P. Emerson, R. Stallard, L. Schlichting, C. Chen, P. Keshaviah and J. Burkart. - Mcgaw Park, Il and Nc.

Program Number 2047 at 5:00
* Icodextrin Can Prolong Technique Survival in CAPD Patients With Ultrafiltration Failure. E.M. Peers and A.C. Scrimgeour. - St. Albans, United Kingdom.

Program Number 2048 at 5:15
* A comparative Clinical Study of Peritoneal Dialysis Solutions Containing Polyglucose and Polyglucose in Combination With Amino Acids. B. Faller, T. Shockley, S. Genestier, S. Gentile, C. De Vos, R. Burke, M. Taminne, D. Faict, R. Guiberteau and L. Martis. - Colmar, France and Mcgaw Park, Il.

Program Number 2050 at 5:45
* Patient Survival on CAPD; Comparison Between Canada and The United States. D.N. Churchill, K.E. Thorpe, E.F. Vonesh and P.R. Keshaviah. - Hamilton, Canada and Chicago, Il.

4:00PM ---Free Communications--- San Diego Conv Ctr Rm 5ab
Morbidity and Mortality in End-stage Renal Disease Patients

Program Number 2106 at 4:45
* Peritonitis influences Mortality in PD Patients. L. Fried, J. Bernardini, J.R. Johnston and B. Piraino. - Pittsburgh, Pa.

Wed. Nov. 8 1995

10:00AM ---Free Communications--- San Diego Conv Ctr Rm 5a
Dialysis Adequacy: Applications and Outcomes

Program Number 2175 at 10:30
* Linkage Between Adequacy of Dialysis and Nutrition in CAPD Patients. F.X. McCusker, B.T. Teehan, P.R. Keshaviah, K.E. Thorpe and D.N. Churchill. - Wynnewood, Pa; Minneapolis, Mn and Hamilton, Canada.

Program Number 2180 at 11:45
* The Peak Concentration Hypothesis Is Not The Grole Story. P.G. Blake and E. Spanner. - London, Canada.

10:00AM ---Free Communications--- San Diego Conv Ctr Rm 8
Nutrition and Metabolism in Dialysis Patients

Program Number 2221 at 11:00
* Correction of Acidosis and Nutrition in CAPD Patients: A randomized Controlled Trial of Low Versus High Alkali Dialysate. A. Stein, J. Moorhouse, F. Baker, J. Johnstone, G. James, J. Troughton, G. Bircher and J. Walls. - Leicester, United Kingdom.

Use BACK arrow on your browser (faster) or click here to go back to ASN95 main page

UP Click on ARROW for HDCN Home Page.